THRB and atrial fibrillation: A recent study conducted in 61 individuals with genetically confirmed THRB mutations showed increased risks for all-cause mortality [hazard ratio (HR) 2.84], atrial fibrillation (HR 10.56), heart failure (HR 6.35), and major adverse cardiovascular events (HR 3.49) compared to controls (10).